Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial

Brown, EA; Minnich, A; Sanyal, AJ; Loomba, R; Du, SY; Schwarz, J; Ehman, RL; Karsdal, M; Leeming, DJ; Cizza, G; Charles, ED

Charles, ED (通讯作者),3401 Princeton Pike, Princeton, NJ 08648 USA.

JHEP REPORTS, 2023; 5 (4):

Abstract

Background & Aims: FALCON 1 was a phase IIb study of pegbelfermin in patients with non-alcoholic steatohepatitis (NASH) and stage 3 fibrosis. This......

Full Text Link